# Study of Neurotidine® Intake on Life Quality of Patients With Glaucoma

> **NCT04046809** · NA · COMPLETED · sponsor: **Omikron Italia S.r.l.** · enrollment: 155 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **OTHER:** Food for special medical purposes: Neurotidine®
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04046809
- **Lead sponsor:** Omikron Italia S.r.l.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-13
- **Primary completion:** 2021-12-07
- **Final completion:** 2022-01-24
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2022-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04046809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04046809, "Study of Neurotidine® Intake on Life Quality of Patients With Glaucoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04046809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*